Board Meeting Details
- Meeting Date: Thursday, October 29, 2026
- Regulatory Reference: Pursuant to Regulation 29 and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Agenda Items
1. Consider and approve the Unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter and half year ended September 30, 2026
2. Consider declaration of Interim Dividend, if any, for the financial year 2026-27
Trading Window Status
- Trading window for dealing in shares of the Company closed from October 1, 2026
- Closure will continue until 48 hours after the declaration of Financial Results
- Regulatory basis: Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015
- Previous intimation made to Stock Exchanges on September 28, 2026
Company Officials
- Company Secretary & Compliance Officer: Manoj Kumar CV
- Contact Address: 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai - 400 022
SEBI Reference Number
SE/2026-27/64